Persantine Oral Tablet 25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Persantine: Oral tablet (25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_14933.JPG
Dipyridamole 25mg Tab
Roxane Laboratories Inc
Pill Identification: 17  |  BI
Drug Image file DrugItem_2629.JPG
Dipyridamole 25mg Tab
Mylan Institutional LLC formerly UDL Laboratories Inc
Pill Identification: b  |  252
Drug Image file DrugItem_2395.JPG
Persantine 25mg Tab
Boehringer Ingelheim Pharmaceuticals Inc
Pill Identification: BI  |  17
Drug Image file DrugItem_3844.JPG
Dipyridamole 25mg Tab
Barr Laboratories Inc a Division of Teva USA
Pill Identification: b  |  252
Drug Image file DrugItem_696.JPG
Dipyridamole 25mg Tab
Major Pharmaceuticals Inc
Pill Identification: b  |  252
Drug Image file DrugItem_4886.JPG
Dipyridamole 25mg Tab
Lederle Pharmaceutical Div American Cyanamid Co
Drug Image file DrugItem_11594.JPG
Dipyridamole 25mg Tab
Zydus Pharmaceuticals (USA) Inc
Pill Identification: ZE 43 

What is this Medicine?

DIPYRIDAMOLE (dye peer ID a mole) is used in patients who have had heart valve replacements. It prevents blood clots and reduces the risk of complications.

In-Depth Information

Persantine 25mg Tablet

NDC: 005970017
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Arterial Thromboembolism Prophylaxis, Prosthetic Heart Valves

Sometimes used for but not FDA approved for the following conditions:
Valvular Heart Disease, Myocardial Infarction Prophylaxis, Transient Ischemic Attack (TIA), Proteinuria, Cardiomyopathy

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Persantine 25mg Tablet
Drug Image file DrugItem_2395.JPG
Boehringer Ingelheim Pharmaceuticals Inc
Pill Identification: BI  |  17
Shape: round
Color: orange

Reported Side Effects for Persantine 25mg Tablet

Headache Incidence:
<12.2%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Breathing Difficulties Incidence:
0.2%*
Severity: SEVERE
Onset: RAPID
Feeling Sick Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
0.3%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
0.3%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
0.4%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
0.7-6.1%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
0.9%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
1.2%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
1.3%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
2.3%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
3.2%*
Severity: MODERATE
Onset: RAPID
Low Blood Pressure Incidence:
4.6%*
Severity: MODERATE
Onset: RAPID
Upset Stomach Incidence:
4.6%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
11.8-13.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Persantine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5